• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Ethical issues in implementation science: perspectives from a National Heart, Lung, and Blood Institute workshop.实施科学中的伦理问题:国家心肺血液研究所研讨会的观点。
Implement Sci. 2024 Nov 19;19(1):77. doi: 10.1186/s13012-024-01403-6.
2
American Society of Clinical Oncology policy statement: oversight of clinical research.美国临床肿瘤学会政策声明:临床研究监督
J Clin Oncol. 2003 Jun 15;21(12):2377-86. doi: 10.1200/JCO.2003.04.026. Epub 2003 Apr 29.
3
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
4
The Effectiveness of Integrated Care Pathways for Adults and Children in Health Care Settings: A Systematic Review.综合护理路径在医疗环境中对成人和儿童的有效性:一项系统评价。
JBI Libr Syst Rev. 2009;7(3):80-129. doi: 10.11124/01938924-200907030-00001.
5
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
6
Re-evaluating ethical concerns in planned emergency research involving critically ill patients: an interpretation of the guidance document from the United States Food and Drug Administration.重新评估涉及重症患者的计划性紧急研究中的伦理问题:对美国食品药品监督管理局指导文件的解读
J Clin Ethics. 2015 Spring;26(1):61-7.
7
The ethical challenges raised in the design and conduct of pragmatic trials: an interview study with key stakeholders.实用临床试验设计和实施中引发的伦理挑战:关键利益攸关方的访谈研究。
Trials. 2019 Dec 23;20(1):765. doi: 10.1186/s13063-019-3899-x.
8
Stakeholder Engagement in Late-Stage Translation Research and Implementation Science: Perspectives From the National Heart, Lung, and Blood Institute.利益相关者参与晚期翻译研究和实施科学:来自国家心肺血液研究所的观点。
Glob Heart. 2019 Jun;14(2):191-194. doi: 10.1016/j.gheart.2019.06.005.
9
Ethical and Regulatory Issues for Embedded Pragmatic Trials Involving People Living with Dementia.涉及痴呆症患者的嵌入式实用临床试验的伦理和监管问题。
J Am Geriatr Soc. 2020 Jul;68 Suppl 2(Suppl 2):S37-S42. doi: 10.1111/jgs.16620.
10
Ethical and practical considerations for interventional HIV cure-related research at the end-of-life: A qualitative study with key stakeholders in the United States.终末期干预性 HIV 治愈相关研究的伦理与实践考量:美国主要利益相关方的定性研究
PLoS One. 2021 Jul 16;16(7):e0254148. doi: 10.1371/journal.pone.0254148. eCollection 2021.

本文引用的文献

1
Ethical Challenges Associated with Pragmatic and Cluster RCTs.与实用和整群随机对照试验相关的伦理挑战。
N Engl J Med. 2024 Sep 19;391(11):969-971. doi: 10.1056/NEJMp2403550. Epub 2024 Sep 14.
2
The ethical value of consulting community members in non-emergency trials conducted with waivers of informed consent for research.在为研究而放弃知情同意的非紧急试验中咨询社区成员的伦理价值。
Clin Trials. 2025 Feb;22(1):100-108. doi: 10.1177/17407745241259360. Epub 2024 Jun 25.
3
A Call for Behavioral Science in Embedded Bioethics.呼吁将行为科学纳入嵌入式生物伦理学。
Perspect Biol Med. 2022;65(4):672-679. doi: 10.1353/pbm.2022.0059.
4
Toward Meeting the Obligation of Respect for Persons in Pragmatic Clinical Trials.迈向满足实用临床试验中尊重人的义务。
Hastings Cent Rep. 2022 May;52(3):9-17. doi: 10.1002/hast.1391.
5
Practical steps to identifying the research risk of pragmatic trials.识别实用临床试验研究风险的实用步骤。
Clin Trials. 2022 Apr;19(2):211-216. doi: 10.1177/17407745211063476. Epub 2022 Mar 29.
6
Predictors of COVID-19 Vaccine Acceptance, Intention, and Hesitancy: A Scoping Review.预测 COVID-19 疫苗接受、意愿和犹豫的因素:范围综述。
Front Public Health. 2021 Aug 13;9:698111. doi: 10.3389/fpubh.2021.698111. eCollection 2021.
7
Implementing nudges to promote utilization of low tidal volume ventilation (INPUT): a stepped-wedge, hybrid type III trial of strategies to improve evidence-based mechanical ventilation management.实施干预措施以推广低潮气量通气(INPUT):采用阶梯式楔形设计,对改善基于证据的机械通气管理策略进行 III 期混合试验。
Implement Sci. 2021 Aug 10;16(1):78. doi: 10.1186/s13012-021-01147-7.
8
Revisiting time to translation: implementation of evidence-based practices (EBPs) in cancer control.重新审视翻译时间:癌症控制中基于证据的实践(EBPs)的实施。
Cancer Causes Control. 2021 Mar;32(3):221-230. doi: 10.1007/s10552-020-01376-z. Epub 2021 Jan 4.
9
The role of data and safety monitoring boards in implementation trials: When are they justified?数据与安全监测委员会在实施试验中的作用:何时具有合理性?
J Clin Transl Sci. 2020 Mar 5;4(3):229-232. doi: 10.1017/cts.2020.19.
10
Using Nudges to Enhance Clinicians' Implementation of Shared Decision Making With Patient Decision Aids.运用助推手段促进临床医生借助患者决策辅助工具实施共同决策。
MDM Policy Pract. 2020 Apr 26;5(1):2381468320915906. doi: 10.1177/2381468320915906. eCollection 2020 Jan-Jun.

实施科学中的伦理问题:国家心肺血液研究所研讨会的观点。

Ethical issues in implementation science: perspectives from a National Heart, Lung, and Blood Institute workshop.

机构信息

Department of Medicine and Emory Health Services Research Center, Emory University School of Medicine, 1750 Haygood Drive #250-N, Atlanta, GA, USA.

Center for Methods On Implementation and Prevention Science, Department of Biostatistics, Yale School of Public Health, New Haven, CT, USA.

出版信息

Implement Sci. 2024 Nov 19;19(1):77. doi: 10.1186/s13012-024-01403-6.

DOI:10.1186/s13012-024-01403-6
PMID:39563405
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11577597/
Abstract

Ethical issues arise in the context of implementation science that may differ from those encountered in other research settings. This report, developed out of a workshop convened by the Center for Translation Research and Implementation Science within the United States National Heart, Lung, and Blood Institute, identifies six key themes that are important to the assessment of ethical dimensions of implementation science. First, addressing ethical challenges in implementation science does not require new ethical principles, commitments, or regulations. However, it does require understanding of the specific contexts arising in implementation research related to both study design and the intervention being implemented. Second, implementation research involves many different types of people in research, including patients, clinicians, administrators, the social networks of any of these, and the general population. These individuals play different roles that may entail different ethical considerations, obligations, and vulnerabilities. Third, the appropriateness of and need for informed consent in implementation research is connected to the role of the subject/participant, the nature of the intervention, and the design of the study. Even where traditional "full" consent processes are unnecessary or inappropriate, communication and engagement are critical. Similarly, even when research is exempt and informed consent unnecessary, Data Safety and Monitoring Board oversight of implementation studies may be advisable to ensure quality, address unexpected consequences, and identify overwhelming evidence of benefit. Fourth, implementation science is often explicitly designed to encourage specific behaviors and discourage others. There is a need for clarity regarding when efforts at behavioral change enhance or threaten autonomy and how to protect participants whose autonomy is threatened. Fifth, there is significant overlap between implementation science and quality improvement, and the ideal regulatory oversight structure for implementation science remains unclear. It is critical to encourage learning and growth while assuring appropriate protections. Sixth, implementation research takes place across a range of social and cultural contexts. Engagement and collaboration with stakeholders in designing and executing implementation trials and studies- especially when vulnerabilities exist- is essential. Attention to these themes will help ensure that implementation science fulfills its goal of advancing the practice of health care within a sound ethical framework.

摘要

伦理问题在实施科学中出现,可能与其他研究环境中遇到的问题不同。本报告由美国国家心肺血液研究所翻译研究与实施科学中心组织的一次研讨会制定,确定了六个重要主题,这些主题对于评估实施科学的伦理维度至关重要。首先,解决实施科学中的伦理挑战并不需要新的伦理原则、承诺或法规。然而,它确实需要了解在与研究设计和实施干预相关的实施研究中出现的具体情况。其次,实施研究涉及研究中的许多不同类型的人,包括患者、临床医生、管理人员、这些人的社交网络以及一般人群。这些人扮演着不同的角色,可能涉及不同的伦理考虑、义务和脆弱性。第三,实施研究中知情同意的适当性和必要性与研究对象/参与者的角色、干预措施的性质以及研究设计有关。即使在不需要或不适当的传统“完整”同意过程的情况下,沟通和参与也至关重要。同样,即使研究是豁免的,不需要知情同意,实施研究的数据安全和监测委员会监督也可能是明智的,以确保质量,解决意外后果,并确定压倒性的受益证据。第四,实施科学通常是为了明确鼓励特定的行为,同时劝阻其他行为。在努力改变行为增强或威胁自主权的情况下,以及在如何保护自主权受到威胁的参与者方面,需要明确性。第五,实施科学与质量改进之间存在很大的重叠,实施科学的理想监管监督结构仍不清楚。鼓励学习和成长的同时确保适当的保护至关重要。第六,实施研究发生在一系列社会和文化背景下。在设计和执行实施试验和研究时,与利益相关者进行接触和合作——特别是在存在脆弱性的情况下——是至关重要的。关注这些主题将有助于确保实施科学在健全的伦理框架内实现其推进医疗保健实践的目标。